查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933077

人工智慧在医学影像领域的应用，全球市场预测至2032年：按组件、模式、技术、应用、最终用户和地区划分

Medical Imaging AI Market Forecasts to 2032 - Global Analysis By Component (Software and Services), Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2025 年，全球用于医学影像的 AI 市场价值将达到 24.6 亿美元，到 2032 年将达到 140.9 亿美元，在预测期内的复合年增长率为 28.3%。

医学影像人工智慧是指将人工智慧（包括机器学习和深度学习演算法）应用于分析和解读医学影像，例如X光、 电脑断层扫描、MRI和超音波。这可以提高诊断准确率，加快影像处理速度，并帮助临床医生检测异常情况、预测疾病进展以及製定个人化治疗方案。透过整合先进的模式识别和数据分析技术，医学影像人工智慧能够支援早期诊断，减少人为错误，并优化医疗环境中的工作流程效率。最终，这将改善患者预后，并实现更精准、数据驱动的临床决策。

慢性病发生率呈上升趋势

心血管疾病、癌症、糖尿病和神经系统疾病等慢性病的日益增加是推动市场发展的主要因素。由于这些疾病需要频繁监测和早期发现，医疗机构越来越依赖人工智慧驱动的影像诊断解决方案来进行准确及时的诊断。先进的演算法能够分析复杂的影像数据，帮助临床医生发现细微的异常、监测疾病进展并制定治疗方案。对慢性病管理精准性和效率的日益增长的需求正在推动全球市场的扩张。

高昂的实施成本

高昂的实施成本仍是医学影像人工智慧技术普及应用的主要障碍。部署人工智慧解决方案需要对硬体、软体和资料基础设施进行大量投资，此外还需要支付人员培训和系统整合费用。中小医疗机构往往面临预算限制，阻碍了人工智慧技术的广泛应用。此外，持续的维护、更新和网路安全措施也会增加营运成本。这些财务障碍会减缓市场渗透速度，尤其是在发展中地区。

技术进步

持续的技术进步为市场带来了巨大的机会。深度学习、神经网路和云端运算领域的创新使得更先进的影像分析和预测建模成为可能。与电子健康记录 (EHR) 和穿戴式装置的整合增强了个人化治疗和监测的效果。此外，演算法精度、计算能力和成像技术的进步正在拓展人工智慧在多个专科领域的应用范围，包括肿瘤学、心臟病学和放射学。这些进步有望加速人工智慧的普及应用，并巩固其在现代医疗保健生态系统中的作用。

监理复杂性

监管的复杂性对市场构成重大威胁。基于人工智慧的诊断影像解决方案必须遵守严格的医疗法规，包括获得美国食品药物管理局 (FDA)、欧洲药品管理局 (EMA) 和地区监管机构等部门的核准。缺乏标准化的评估框架、不断变化的指南以及对资料隐私和病患安全的担忧，都可能导致产品上市延迟和合规成本增加。地区监管差异进一步加剧了全球市场准入的困难度。这些挑战有可能阻碍创新和应用，因此，开发商和医疗服务提供者必须认真考虑复杂的法律体制。

新冠疫情的影响：

新冠疫情对医学影像人工智慧市场产生了重大影响，加速了对自动化和远距离诊断工具的需求。人工智慧辅助影像技术帮助临床医生快速检测新冠患者的肺部异常，从而支援早期疗育和高效的资源配置。疫情对常规医疗服务的衝击也凸显了高效成像工作流程和远端医疗整合的必要性。因此，随着医院和诊断中心寻求扩充性、精准且非接触式的诊断工具，对人工智慧解决方案的投资激增。

在预测期内，机器学习领域将占据最大的市场规模。

预计在预测期内，机器学习领域将占据最大的市场份额。机器学习演算法能够从海量资料集中学习，随着时间的推移不断提高诊断准确率，并识别传统分析方法可能遗漏的医学影像中的复杂模式。这些解决方案支援广泛的应用，包括肿瘤检测和器官分割。其扩充性和持续提升效能的能力使其成为诊断工作流程中不可或缺的一部分，推动了其在全球医院、诊断中心和研究机构的广泛应用。

在预测期内，诊断中心细分市场将实现最高的复合年增长率。

预计在预测期内，诊断中心细分市场将实现最高成长率，因为对快速、精准诊断服务的需求不断增长，促使这些中心采用人工智慧驱动的成像解决方案，从而优化工作流程、缩短处理时间并提高准确性。与大型医院不同，诊断中心可以更快采用人工智慧工具，获得更具成本效益的解决方案和专业服务。随着这些中心成像能力的扩展，人工智慧的整合将使它们能够高效处理不断增长的患者数量并改善临床决策，从而推动市场强劲成长。

占比最大的地区：

在预测期内，北美预计将占据最大的市场份额，这得益于其先进的医疗基础设施、对最尖端科技的积极应用以及强大的研发投入。主要人工智慧开发商和成熟医疗服务提供者的存在，正在推动人工智慧解决方案的快速整合。有利的报销政策和对精准医疗日益增长的关注，进一步加速了人工智慧的普及应用。对早期诊断、工作流程效率和数据驱动的临床决策日益增长的需求，必将确保北美在全球医学影像人工智慧发展领域保持领先地位。

预计年复合成长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于慢性病患病率上升和医疗基础设施投资增加所推动的需求增长。各国政府，尤其是中国和印度等新兴经济体的政府，正积极推广人工智慧技术的应用，以提高诊断效率。诊断中心的扩建以及人们对人工智慧临床益处的认识不断提高，都促进了人工智慧技术的广泛应用。此外，技术提供者和医疗机构之间的区域合作也推动了人工智慧技术快速融入区域医疗系统。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要参与者（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 基于产品系列、地域覆盖范围和策略联盟对主要参与者进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球医疗影像人工智慧市场（按组件划分）

  • 软体
  • 服务

6. 全球医学影像人工智慧市场（以影像方式划分）

  • X射线影像
  • CT（电脑断层扫描）
  • 磁振造影（MRI）
  • 超音波成像
  • PET（正子断层扫描）
  • 乳房X光摄影
  • 其他的

7. 全球医疗影像人工智慧市场（按技术划分）

  • 机器学习
  • 深度学习
  • 自然语言处理（NLP）

8. 全球人工智慧医疗影像市场（按应用领域划分）

  • 放射成像
  • 心血管影像
  • 肿瘤影像
  • 神经影像学
  • 肌肉骨骼影像
  • 其他的

9. 全球医学影像人工智慧市场（按最终用户划分）

  • 医院和诊所
  • 诊断中心
  • 研究和学术机构
  • 其他的

第十一章 全球医疗影像人工智慧市场（按地区划分）

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • GE HealthCare
  • Butterfly Network
  • Siemens Healthineers AG
  • EchoNous, Inc.
  • Koninklijke Philips NV
  • Avicenna.AI
  • IBM Watson Health
  • Agfa-Gevaert Group
  • NVIDIA Corporation
  • Gleamer
  • Microsoft Corporation
  • Canon Medical Systems
  • Aidoc
  • Arterys
  • Zebra Medical Vision
Product Code: SMRC33645

According to Stratistics MRC, the Global Medical Imaging AI Market is accounted for $2.46 billion in 2025 and is expected to reach $14.09 billion by 2032 growing at a CAGR of 28.3% during the forecast period. Medical Imaging AI refers to the application of artificial intelligence, including machine learning and deep learning algorithms, to analyze and interpret medical images such as X-rays, CT scans, MRI, and ultrasound. It enhances diagnostic accuracy, accelerates image processing, and assists clinicians in detecting abnormalities, predicting disease progression, and personalizing treatment plans. By integrating advanced pattern recognition and data analytics, Medical Imaging AI supports early diagnosis, reduces human error, and optimizes workflow efficiency in healthcare settings, ultimately improving patient outcomes and enabling more precise, data driven clinical decision making.

Market Dynamics:

Driver:

Growing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, diabetes, and neurological conditions is a major driver for the market. As these diseases often require frequent monitoring and early detection, healthcare providers increasingly rely on AI-powered imaging solutions for accurate and timely diagnosis. Advanced algorithms enable the analysis of complex imaging data, supporting clinicians in detecting subtle abnormalities, monitoring disease progression, and planning treatment. This growing demand for precision and efficiency in chronic disease management fuels market expansion globally.

Restraint:

High Implementation Costs

High implementation costs remain a key restraint for the adoption of Medical Imaging AI technologies. The deployment of AI solutions involves substantial investments in hardware, software, and data infrastructure, alongside expenses for staff training and system integration. Small and medium healthcare facilities often face budgetary constraints, limiting widespread adoption. Additionally, ongoing maintenance, updates, and cybersecurity measures contribute to operational costs. These financial barriers can slow market penetration, particularly in developing regions.

Opportunity:

Advancements in technology

Continuous technological advancements present significant opportunities for the market. Innovations in deep learning, neural networks, and cloud computing enable more sophisticated image analysis and predictive modeling. Integration with electronic health records (EHRs) and wearable devices enhance personalized treatment and monitoring. Furthermore, improvements in algorithm accuracy, computational power, and imaging modalities expand AI's applications across multiple specialties, including oncology, cardiology, and radiology. These advancements are expected to accelerate adoption and strengthen AI's role in modern healthcare ecosystems.

Threat:

Regulatory Complexity

Regulatory complexity poses a substantial threat to the market. AI-based imaging solutions must comply with stringent healthcare regulations, including approvals from agencies like the FDA, EMA, and regional authorities. The lack of standardized evaluation frameworks, evolving guidelines, and concerns over data privacy and patient safety can delay product launches and increase compliance costs. Variability in regional regulations further complicates global market entry. These challenges may hinder innovation and adoption, requiring developers and healthcare providers to navigate intricate legal frameworks.

Covid-19 Impact:

The COVID-19 pandemic has significantly influenced the Medical Imaging AI market, accelerating demand for automated and remote diagnostic tools. AI-assisted imaging helped clinicians rapidly detect lung abnormalities in COVID-19 patients, supporting early intervention and efficient resource allocation. Pandemic-driven disruptions in routine healthcare also highlighted the need for efficient imaging workflows and telehealth integration. Consequently, investment in AI solutions surged as hospitals and diagnostic centers sought scalable, accurate, and contactless diagnostic tools.

The machine learning segment is expected to be the largest during the forecast period

The machine learning segment is expected to account for the largest market share during the forecast period, as machine learning algorithms can learn from vast datasets, improving diagnostic accuracy over time and identifying complex patterns in medical images that may be missed by conventional analysis. These solutions support a wide range of applications, including tumor detection and organ segmentation. Their scalability and ability to continuously improve performance make them indispensable in diagnostic workflows, driving widespread adoption across hospitals, diagnostic centers, and research institutions globally.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic centers segment is predicted to witness the highest growth rate, due to demand for quick and accurate diagnostic services has led these centers to adopt AI-powered imaging solutions that optimize workflow, reduce turnaround times, and enhance precision. Unlike large hospitals, diagnostic centers can implement AI tools more rapidly, benefiting from cost-effective solutions and specialized services. As these centers expand their imaging capabilities, integrating AI allows them to handle increased patient volumes efficiently and improve clinical decision making, fueling strong market growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, owing to region's advanced healthcare infrastructure, high adoption of cutting-edge technology, and strong R&D investments. The presence of major AI developers and established healthcare providers fosters rapid integration of AI solutions. Favorable reimbursement policies and growing focus on precision medicine further accelerate adoption. Increasing demand for early diagnosis, workflow efficiency, and data-driven clinical decision-making ensures that North America remains at the forefront of Medical Imaging AI growth globally.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to increasing prevalence of chronic diseases, and rising healthcare infrastructure investments drive demand. Governments are promoting AI adoption to enhance diagnostic efficiency, particularly in emerging economies like China and India. The expansion of diagnostic centers coupled with growing awareness of AI's clinical benefits, supports widespread deployment. Additionally, local partnerships and collaborations between technology providers and healthcare institutions facilitate accelerated integration of AI into regional healthcare systems.

Key players in the market

Some of the key players in Medical Imaging AI Market include GE HealthCare, Butterfly Network, Siemens Healthineers AG, EchoNous, Inc., Koninklijke Philips N.V., Avicenna.AI, IBM Watson Health, Agfa-Gevaert Group, NVIDIA Corporation, Gleamer, Microsoft Corporation, Canon Medical Systems, Aidoc, Arterys and Zebra Medical Vision.

Key Developments:

In September 2025, Philips and Masimo have renewed and expanded their multi year strategic partnership to accelerate development and delivery of next generation patient monitoring technologies, integrating Masimo's advanced measurement tools into Philips' platforms to enhance clinician decision making and connected care worldwide.

In July 2025, Philips and Medtronic have deepened their decades old alliance with a fresh multi year patient monitoring partnership, weaving Medtronic's leading sensors and technologies into Philips' systems to enhance clinical insight, streamline care delivery, and broaden global access to advanced monitoring solutions.

Components Covered:

  • Software
  • Services

Modalities Covered:

  • X-ray Imaging
  • CT (Computed Tomography)
  • MRI (Magnetic Resonance Imaging)
  • Ultrasound Imaging
  • PET (Positron Emission Tomography)
  • Mammography
  • Other Modalities

Technologies Covered:

  • Machine Learning
  • Deep Learning
  • Natural Language Processing (NLP)

Applications Covered:

  • Radiology Imaging
  • Cardiovascular Imaging
  • Oncology Imaging
  • Neurology Imaging
  • Musculoskeletal Imaging
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Research & Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Imaging AI Market, By Component

  • 5.1 Introduction
  • 5.2 Software
  • 5.3 Services

6 Global Medical Imaging AI Market, By Modality

  • 6.1 Introduction
  • 6.2 X-ray Imaging
  • 6.3 CT (Computed Tomography)
  • 6.4 MRI (Magnetic Resonance Imaging)
  • 6.5 Ultrasound Imaging
  • 6.6 PET (Positron Emission Tomography)
  • 6.7 Mammography
  • 6.8 Other Modalities

7 Global Medical Imaging AI Market, By Technology

  • 7.1 Introduction
  • 7.2 Machine Learning
  • 7.3 Deep Learning
  • 7.4 Natural Language Processing (NLP)

8 Global Medical Imaging AI Market, By Application

  • 8.1 Introduction
  • 8.2 Radiology Imaging
  • 8.3 Cardiovascular Imaging
  • 8.4 Oncology Imaging
  • 8.5 Neurology Imaging
  • 8.6 Musculoskeletal Imaging
  • 8.7 Other Applications

9 Global Medical Imaging AI Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Diagnostic Centers
  • 9.4 Research & Academic Institutes
  • 9.5 Other End Users

11 Global Medical Imaging AI Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 GE HealthCare
  • 13.2 Butterfly Network
  • 13.3 Siemens Healthineers AG
  • 13.4 EchoNous, Inc.
  • 13.5 Koninklijke Philips N.V.
  • 13.6 Avicenna.AI
  • 13.7 IBM Watson Health
  • 13.8 Agfa-Gevaert Group
  • 13.9 NVIDIA Corporation
  • 13.10 Gleamer
  • 13.11 Microsoft Corporation
  • 13.12 Canon Medical Systems
  • 13.13 Aidoc
  • 13.14 Arterys
  • 13.15 Zebra Medical Vision

List of Tables

  • Table 1 Global Medical Imaging AI Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Medical Imaging AI Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Medical Imaging AI Market Outlook, By Software (2024-2032) ($MN)
  • Table 4 Global Medical Imaging AI Market Outlook, By Services (2024-2032) ($MN)
  • Table 5 Global Medical Imaging AI Market Outlook, By Modality (2024-2032) ($MN)
  • Table 6 Global Medical Imaging AI Market Outlook, By X-ray Imaging (2024-2032) ($MN)
  • Table 7 Global Medical Imaging AI Market Outlook, By CT (Computed Tomography) (2024-2032) ($MN)
  • Table 8 Global Medical Imaging AI Market Outlook, By MRI (Magnetic Resonance Imaging) (2024-2032) ($MN)
  • Table 9 Global Medical Imaging AI Market Outlook, By Ultrasound Imaging (2024-2032) ($MN)
  • Table 10 Global Medical Imaging AI Market Outlook, By PET (Positron Emission Tomography) (2024-2032) ($MN)
  • Table 11 Global Medical Imaging AI Market Outlook, By Mammography (2024-2032) ($MN)
  • Table 12 Global Medical Imaging AI Market Outlook, By Other Modalities (2024-2032) ($MN)
  • Table 13 Global Medical Imaging AI Market Outlook, By Technology (2024-2032) ($MN)
  • Table 14 Global Medical Imaging AI Market Outlook, By Machine Learning (2024-2032) ($MN)
  • Table 15 Global Medical Imaging AI Market Outlook, By Deep Learning (2024-2032) ($MN)
  • Table 16 Global Medical Imaging AI Market Outlook, By Natural Language Processing (NLP) (2024-2032) ($MN)
  • Table 17 Global Medical Imaging AI Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Medical Imaging AI Market Outlook, By Radiology Imaging (2024-2032) ($MN)
  • Table 19 Global Medical Imaging AI Market Outlook, By Cardiovascular Imaging (2024-2032) ($MN)
  • Table 20 Global Medical Imaging AI Market Outlook, By Oncology Imaging (2024-2032) ($MN)
  • Table 21 Global Medical Imaging AI Market Outlook, By Neurology Imaging (2024-2032) ($MN)
  • Table 22 Global Medical Imaging AI Market Outlook, By Musculoskeletal Imaging (2024-2032) ($MN)
  • Table 23 Global Medical Imaging AI Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 24 Global Medical Imaging AI Market Outlook, By End User (2024-2032) ($MN)
  • Table 25 Global Medical Imaging AI Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 26 Global Medical Imaging AI Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 27 Global Medical Imaging AI Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 28 Global Medical Imaging AI Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.